Search

everythinglearnresearchcommunity

for

Search:↓

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Hair loss in women is often due to hereditary conditions or stress, and while treatments like minoxidil can help, diagnosis and management require medical guidance.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

EF and PXE not closely related.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.